87 results
Page 3 of 5
8-K
EX-99.1
3l931ib8xhyxxfie
1 Sep 22
Inhibikase Therapeutics Appoints Gisele Dion to Board of Directors
5:30pm
8-K
EX-10.1
19nkbssbsxr2gpw9
16 May 22
Entry into a Material Definitive Agreement
9:49pm
424B5
cg1xkjnvvz
16 May 22
Prospectus supplement for primary offering
9:47pm
PRE 14A
0gy5vgu8ql71jf1
21 Apr 22
Preliminary proxy
4:33pm
S-3
eyjn9dddnpyat0kbgae
7 Feb 22
Shelf registration
12:00am
8-K
EX-99.1
41px6vf43dga
21 Jun 21
Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock
9:23am
424B4
utj hzq2h8
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
758kneszhrnz9q
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
8-K
4lf7gqil 3g
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
8-K
EX-99.1
ooq4qoaqwog7v17 kt
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
hqca1syi12 fj
2 Jun 21
Draft registration statement
12:00am
DRS
EX-1.1
5aj1i1z7p8foyehhx7b
2 Jun 21
Draft registration statement
12:00am